A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: obtain (280), request (403)

Anti-VEGF injection treatment aftercare - patient information

Description
Anti-VEGF injections are used to treat conditions that can cause abnormal blood vessels to leak under the retina (the layer
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Anti-VEGF-injection-treatment-aftercare-1365-PIL.pdf

Wessex adult cystic fibrosis (CF) service - patient information

Description
This factsheet contains important information about our adult cystic fibrosis (CF) service.
Url
/Media/UHS-website-2019/Patientinformation/Respiratory/Wessex-adult-cystic-fibrosis-CF-service-3544-PIL.pdf

Institutional information_2022-23_final

Description
Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same document
Url
/Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2022-23-final.pdf

Physiotherapy resources - patient information

Description
This factsheet contains some useful resources for people living in Southampton with a condition affecting the joints or muscles.
Url
/Media/UHS-website-2019/Patientinformation/Muscles,jointsandbones/Physiotherapy-resources-3328-PIL.pdf

Daylight photodynamic therapy (PDT) - patient information

Description
This factsheet explains what daylight photodynamic therapy (PDT) is and what it involves, so you know what to expect at your
Url
/Media/UHS-website-2019/Patientinformation/Skin/Daylight-photodynamic-therapy-PDT-2165-PIL.pdf

Cisplatin-Pembrolizumab-Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Cisplatin-Pembrolizumab-Pemetrexed Indication •
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Cisplatin-Pembrolizumab-Pemetrexed.pdf

InP RCODOX M(66) cyclophosphamide doxorubicin methotrexate rituximab vincristine

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-METHOTREXATE-RITUXIMAB-VINCRISTINE (RCODOX-M) 66 years and above Inpa
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RCODOX-M66-cyclophosphamide-doxorubicin-methotrexate-rituximab-vincristine.pdf

InP RCODOX M(65) cyclophosphamide doxorubicin methotrexate rituximab vincristine

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-METHOTREXATE-RITUXIMAB-VINCRISTINE (RCODOX-M) 65 years and below Inpa
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RCODOX-M65-cyclophosphamide-doxorubicin-methotrexate-rituximab-vincristine.pdf

DVd_Twice weekly_Daratumumab-Bortezomib-Dexamethasone_Cycles 1 to 8

Description
Chemotherapy Protocol Myeloma DVd (twice weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (twic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Twice-weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone Cycles 1 to 8

Description
Chemotherapy Protocol Myeloma DVd (Weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (weekly)-Da
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf
271 to 280 of 565
Previous … 26 27 28 29 30 … Next